Analystreport

Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target raised by analysts at Needham & Company LLC from $52.00 to $60.00.

Cytokinetics, Incorporated  (CYTK) 
Last cytokinetics, incorporated earnings: 3/3 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytokinetics.com/investor-overview